{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:44:45Z","timestamp":1793659485437,"version":"4.5.1"},"reference-count":107,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000042","name":"Amgen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015650","name":"Canon Medical Systems Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015650","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jacc.2020.08.078","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T18:31:01Z","timestamp":1604341861000},"page":"2252-2266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Evaluation and Management of Patients\u00a0With Stable Angina: Beyond the Ischemia Paradigm"],"prefix":"10.1016","volume":"76","author":[{"given":"Richard","family":"Ferraro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Latina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulhamied","family":"Alfaddagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin D.","family":"Michos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Blaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Trost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Boden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o A.C.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Arbab-Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2020.08.078_bib1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1377\/hlthaff.2018.05499","article-title":"National health expenditure projections, 2018\u201327: Economic and demographic trends drive spending and enrollment growth","volume":"38","author":"Sisko","year":"2019","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.jacc.2020.08.078_bib2","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.08.078_bib3","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/jamacardio.2016.3153","article-title":"Cardiac stress test trends among US patients younger than 65 years, 2005\u20132012","volume":"1","author":"Kini","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib4","first-page":"353","article-title":"Health resource utilization and direct costs associated with angina for patients with coronary artery disease in a US managed care setting","volume":"4","author":"Kempf","year":"2011","journal-title":"Am Health Drug Benefits"},{"key":"10.1016\/j.jacc.2020.08.078_bib5","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJMe2000239","article-title":"Managing stable ischemic heart disease","volume":"382","author":"Antman","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib6","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1172\/JCI135959","article-title":"Stable ischemic heart disease: how to keep it that way","volume":"130","author":"Leucker","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2020.08.078_bib7","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib8","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib9","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamacardio.2020.0822","article-title":"Association of sex with severity of coronary artery disease, ischemia, and symptom burden in patients with moderate or severe ischemia: secondary analysis of the ISCHEMIA randomized clinical trial","volume":"5","author":"Reynolds","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/01.CIR.0000020688.24874.90","article-title":"Health status predicts long-term outcome in outpatients with coronary disease","volume":"106","author":"Spertus","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.08.078_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/clc.22628","article-title":"The prevalence and management of angina among patients with chronic coronary artery disease across US outpatient cardiology practices: Insights from the angina prevalence and provider evaluation of angina relief (APPEAR) study","volume":"40","author":"Kureshi","year":"2017","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib13","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.amjcard.2014.07.009","article-title":"Frequency of angina pectoris and secondary events in patients with stable coronary heart disease (from the Heart and Soul Study)","volume":"114","author":"Beatty","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib14","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jamainternmed.2014.3773","article-title":"Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: Data from the international observational CLARIFY registry","volume":"174","author":"Steg","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib15","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1415516","article-title":"Outcomes of anatomical versus functional testing for coronary artery disease","volume":"372","author":"Douglas","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib16","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"Fihn","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib17","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1161\/CIRCULATIONAHA.113.001258","article-title":"Unstable angina: is it time for a requiem?","volume":"127","author":"Braunwald","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.08.078_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jamainternmed.2018.5124","article-title":"Temporal trends in unstable angina diagnosis codes for outpatient percutaneous coronary interventions","volume":"179","author":"Wadhera","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jamainternmed.2018.5967","article-title":"Gaming, upcoding, fraud, and the stubborn persistence of unstable angina","volume":"179","author":"McNeely","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/CIR.0000000000000366","article-title":"Heart disease and stroke statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.08.078_bib21","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.jacc.2012.08.966","article-title":"A\u00a0contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the united states: a report from the CathPCI registry of the national cardiovascular data registry, 2010 through June 2011","volume":"60","author":"Dehmer","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJMoa072771","article-title":"Effect of PCI on quality of life in patients with stable coronary disease","volume":"359","author":"Weintraub","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib23","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.08.078_bib25","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1161\/CIRCULATIONAHA.118.033801","article-title":"Fractional flow reserve and instantaneous wave-free ratio as predictors of the placebo-controlled response to percutaneous coronary intervention in stable single-vessel coronary artery disease","volume":"138","author":"Al-Lamee","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.08.078_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004665","article-title":"Faith healing' and 'subtraction anxiety' in unblinded trials of procedures: lessons from DEFER and FAME-2 for end points in the ISCHEMIA trial","volume":"11","author":"Rajkumar","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2020.08.078_bib27","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/CIRCULATIONAHA.111.047431","article-title":"Acute coronary events","volume":"125","author":"Arbab-Zadeh","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.08.078_bib28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijcard.2013.08.096","article-title":"Association of cardiac events with coronary artery disease detected by 64-slice or greater coronary CT angiography: a systematic review and meta-analysis","volume":"169","author":"Habib","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib29","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/j.jacc.2016.08.069","article-title":"The risk continuum of atherosclerosis and its implications for defining CHD by coronary angiography","volume":"68","author":"Arbab-Zadeh","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib30","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jacc.2014.11.041","article-title":"The myth of the vulnerable plaque\u2014transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment","volume":"65","author":"Arbab-Zadeh","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib31","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","volume":"58","author":"Smith","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib32","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.jacc.2018.08.2163","article-title":"Healthy behavior, risk factor control, and survival in the COURAGE trial","volume":"72","author":"Maron","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jacc.2015.06.019","article-title":"Comprehensive cardiovascular risk factor control improves survival: the BARI 2D trial","volume":"66","author":"Bittner","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib34","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacc.2016.06.005","article-title":"Assessing the impact of medication adherence on long-term cardiovascular outcomes","volume":"68","author":"Bansilal","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib35","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib36","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib37","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib38","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib42","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jacc.2019.06.043","article-title":"Reduction in first and total ischemic events with icosapent ethyl across baseline triglyceride tertiles","volume":"74","author":"Bhatt","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib43","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib44","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib45","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jacc.2018.11.053","article-title":"PCI and CABG for treating stable coronary artery disease: JACC review topic of the week","volume":"73","author":"Doenst","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib46","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(94)91963-1","article-title":"Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the coronary artery bypass graft surgery trialists collaboration","volume":"344","author":"Yusuf","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.08.078_bib47","doi-asserted-by":"crossref","first-page":"392","DOI":"10.7326\/M13-1380","article-title":"Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trial","volume":"161","author":"Mark","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib48","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jamainternmed.2013.12855","article-title":"Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials","volume":"174","author":"Stergiopoulos","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib49","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A\u00a0randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Frye","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib50","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/CIRCULATIONAHA.120.048194","article-title":"Routine revascularization versus initial medical therapy for stable ischemic heart disease: a systematic review and meta-analysis of randomized trials","volume":"142","author":"Bangalore","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.08.078_bib51","first-page":"CD005158","article-title":"Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events","volume":"12","author":"Squizzato","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2020.08.078_bib52","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30\u00a0months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib53","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jacc.2019.12.067","article-title":"Nonculprit lesion myocardial infarction following percutaneous coronary intervention in patients with acute coronary syndrome","volume":"75","author":"Scirica","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib54","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/eurheartj\/ehz821","article-title":"Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54","volume":"41","author":"Furtado","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.08.078_bib55","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.jacc.2019.07.062","article-title":"From detecting the vulnerable plaque to managing the vulnerable patient","volume":"74","author":"Arbab-Zadeh","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib56","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib57","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib58","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib59","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib60","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005079","article-title":"Effect of coronary anatomy and myocardial ischemia on long-term survival in patients with stable ischemic heart disease","volume":"12","author":"Weintraub","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2020.08.078_bib61","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jacc.2011.09.066","article-title":"Patient management after noninvasive cardiac imaging results from SPARC (study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease)","volume":"59","author":"Hachamovitch","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib62","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jcin.2013.10.017","article-title":"Predicting outcome in the COURAGE trial: coronary anatomy versus ischemia","volume":"7","author":"Mancini","year":"2014","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2020.08.078_bib63","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa1915925","article-title":"Management of coronary disease in patients with advanced kidney disease","volume":"382","author":"Bangalore","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib64","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/CIRCOUTCOMES.108.775247","article-title":"One-year costs in patients with a history of or at risk for atherothrombosis in the United States","volume":"1","author":"Mahoney","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2020.08.078_bib65","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jamacardio.2017.3655","article-title":"Updated cost-effectiveness assessments of PCSK9 inhibitors from the perspectives of the health system and private payers: Insights derived from the FOURIER trial","volume":"2","author":"Arrieta","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib66","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jcin.2009.05.012","article-title":"Percutaneous coronary intervention complications and guide catheter size: bigger is not better","volume":"2","author":"Grossman","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2020.08.078_bib67","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcin.2016.04.014","article-title":"Radial versus femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease: a meta-analysis of randomized trials","volume":"9","author":"Ferrante","year":"2016","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2020.08.078_bib68","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ihj.2017.06.012","article-title":"Complications after elective percutaneous coronary interventions: a comparison between public and private hospitals","volume":"70","author":"Ferreira","year":"2018","journal-title":"Indian Heart J"},{"key":"10.1016\/j.jacc.2020.08.078_bib69","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jacc.2006.04.102","article-title":"Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality","volume":"48","author":"Prasad","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib70","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/hc3101.093902","article-title":"Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients","volume":"104","author":"Stone","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.08.078_bib71","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jacc.2009.03.063","volume":"54","author":"Prasad","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib72","article-title":"Varying definitions for periprocedural myocardial infarction alter event rates and prognostic implications","volume":"3","author":"Idris","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2020.08.078_bib73","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/01.CIR.0000156328.28485.AD","article-title":"Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging","volume":"111","author":"Selvanayagam","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.08.078_bib74","article-title":"Silent brain infarcts following cardiac procedures: a systematic review and meta-analysis","volume":"8","author":"Indja","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2020.08.078_bib75","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa022066","article-title":"Silent brain infarcts and the risk of dementia and cognitive decline","volume":"348","author":"Vermeer","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib76","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jcin.2018.01.248","article-title":"Burden of 30-day readmissions after percutaneous coronary intervention in 833,344 patients in the united states: predictors, causes, and cost: insights from the nationwide readmission database","volume":"11","author":"Kwok","year":"2018","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2020.08.078_bib77","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2147\/CEOR.S89331","article-title":"Patient-level costs of major cardiovascular conditions: a review of the international literature","volume":"8","author":"Nicholson","year":"2016","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.jacc.2020.08.078_bib78","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/CIRCULATIONAHA.112.147488","article-title":"Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: Results from the FREEDOM trial","volume":"127","author":"Magnuson","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.08.078_bib79","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/CIRCOUTCOMES.108.798462","article-title":"Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients","volume":"1","author":"Weintraub","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2020.08.078_bib80","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/jama.2014.14681","article-title":"Nonobstructive coronary artery disease and risk of myocardial infarction","volume":"312","author":"Maddox","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2020.08.078_bib81","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCIMAGING.113.001047","article-title":"Prognostic value of non-obstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events","volume":"7","author":"Bittencourt","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2020.08.078_bib82","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1161\/CIRCULATIONAHA.116.024360","article-title":"Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: Insights from the PROMISE trial (prospective multicenter imaging study for evaluation of chest pain)","volume":"135","author":"Hoffmann","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.08.078_bib83","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1805971","article-title":"Coronary CT angiography and 5-year risk of myocardial infarction","volume":"379","author":"Newby","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib84","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.004419","article-title":"Clinical outcomes after evaluation of stable chest pain by coronary computed tomographic angiography versus usual care: a meta-analysis","volume":"9","author":"Bittencourt","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2020.08.078_bib85","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.jacc.2017.01.046","article-title":"Functional testing or coronary computed tomography angiography in patients with stable coronary artery disease","volume":"69","author":"Jorgensen","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib86","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa0807611","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention","volume":"360","author":"Tonino","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib87","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.109.925396","article-title":"Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease","volume":"122","author":"Fearon","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.08.078_bib88","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/CIRCULATIONAHA.113.003583","article-title":"Fractional flow reserve guided percutaneous coronary intervention is not a valid concept","volume":"129","author":"Arbab-Zadeh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.08.078_bib89","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMe0904090","article-title":"Diabetes with coronary disease\u2014a moving target amid evolving therapies?","volume":"360","author":"Boden","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib90","first-page":"349","article-title":"ISIS-2 (second international study of infarct survival) collaborative group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.08.078_bib91","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.08.078_bib92","first-page":"390","article-title":"Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials","volume":"37","author":"Udell","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.08.078_bib93","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijcard.2017.03.046","article-title":"Antithrombotic agents for secondary prevention after acute coronary syndromes: a systematic review and network meta-analysis","volume":"241","author":"Fanaroff","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2020.08.078_bib94","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A\u00a0randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.08.078_bib95","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(17)32458-3","article-title":"Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Connolly","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.08.078_bib96","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib97","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa042739","article-title":"Angiotensin-converting-enzyme inhibition in stable coronary artery disease","volume":"351","author":"Braunwald","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib98","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14974-4","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.08.078_bib99","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","article-title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial","volume":"372","author":"Yusuf","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.08.078_bib100","doi-asserted-by":"crossref","first-page":"i4801","DOI":"10.1136\/bmj.i4801","article-title":"Beta blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study","volume":"354","author":"Puymirat","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2020.08.078_bib101","first-page":"1383","article-title":"Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.08.078_bib102","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib103","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib104","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2020.08.078_bib105","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib106","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.08.078_bib107","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720371850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720371850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:36:56Z","timestamp":1760017016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109720371850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":107,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0735109720371850"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2020.08.078","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation and Management of Patients\u00a0With Stable Angina: Beyond the Ischemia Paradigm","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.08.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}